LU86973A1 - Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale - Google Patents

Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale Download PDF

Info

Publication number
LU86973A1
LU86973A1 LU86973A LU86973A LU86973A1 LU 86973 A1 LU86973 A1 LU 86973A1 LU 86973 A LU86973 A LU 86973A LU 86973 A LU86973 A LU 86973A LU 86973 A1 LU86973 A1 LU 86973A1
Authority
LU
Luxembourg
Prior art keywords
cerebral
treatment
sequelae
active ingredient
compound
Prior art date
Application number
LU86973A
Other languages
English (en)
French (fr)
Inventor
Hiroyuki Nabata
Yukifumi Noda
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of LU86973A1 publication Critical patent/LU86973A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
LU86973A 1986-08-27 1987-08-26 Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale LU86973A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19879686 1986-08-27
JP19879686 1986-08-27

Publications (1)

Publication Number Publication Date
LU86973A1 true LU86973A1 (fr) 1987-12-16

Family

ID=16397046

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86973A LU86973A1 (fr) 1986-08-27 1987-08-26 Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale

Country Status (22)

Country Link
US (1) US4870090A (cs)
JP (1) JPH07121863B2 (cs)
KR (1) KR950002151B1 (cs)
AU (1) AU603375B2 (cs)
BE (1) BE1003959A5 (cs)
CA (1) CA1302888C (cs)
CH (1) CH672069A5 (cs)
DE (1) DE3728499A1 (cs)
DK (1) DK171392B1 (cs)
FI (1) FI873727L (cs)
FR (1) FR2605222B1 (cs)
GB (1) GB2195532B (cs)
HK (1) HK64993A (cs)
IE (1) IE60601B1 (cs)
IT (1) IT1211477B (cs)
LU (1) LU86973A1 (cs)
NL (1) NL8701994A (cs)
NO (1) NO873571L (cs)
NZ (1) NZ221564A (cs)
SE (1) SE502323C2 (cs)
SG (1) SG52393G (cs)
ZA (1) ZA876401B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
WO1999020284A1 (en) * 1997-10-23 1999-04-29 Trustees Of The University Of Pennsylvania Methods for reducing ischemic injury of the heart via the sequential administration of monophosphoryl lipid a and adenosine receptor agents
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CN107773545A (zh) 2016-08-29 2018-03-09 烟台益诺依生物医药科技有限公司 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB1562962A (en) * 1976-04-02 1980-03-19 Chugai Pharmaceutical Co Ltd Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same
EP0223811A1 (en) * 1985-05-22 1987-06-03 Beecham Group Plc Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US4696934A (en) * 1986-01-10 1987-09-29 Warner-Lambert Company Method for using nifedipine for treating stroke
WO1987005508A1 (en) * 1986-03-14 1987-09-24 Medical College Of Wisconsin Research Foundation, Method of treatment and prevention of cerebral vasospasms

Also Published As

Publication number Publication date
SE502323C2 (sv) 1995-10-02
GB2195532A (en) 1988-04-13
CH672069A5 (cs) 1989-10-31
NO873571D0 (no) 1987-08-24
KR880002525A (ko) 1988-05-09
DE3728499A1 (de) 1988-03-03
HK64993A (en) 1993-07-16
IT8767725A0 (it) 1987-08-21
FI873727A7 (fi) 1988-02-28
IT1211477B (it) 1989-11-03
SE8703308L (sv) 1988-02-28
IE60601B1 (en) 1994-07-27
IE872218L (en) 1988-02-27
FI873727L (fi) 1988-02-28
NL8701994A (nl) 1988-03-16
JPH07121863B2 (ja) 1995-12-25
BE1003959A5 (fr) 1992-07-22
KR950002151B1 (ko) 1995-03-14
FI873727A0 (fi) 1987-08-27
GB8720219D0 (en) 1987-10-07
FR2605222B1 (fr) 1991-02-22
NZ221564A (en) 1999-08-30
US4870090A (en) 1989-09-26
GB2195532B (en) 1990-05-23
FR2605222A1 (fr) 1988-04-22
JPS63152317A (ja) 1988-06-24
AU7731187A (en) 1988-03-03
DK441987A (da) 1988-02-28
CA1302888C (en) 1992-06-09
NO873571L (no) 1988-02-29
DK441987D0 (da) 1987-08-25
DK171392B1 (da) 1996-10-14
ZA876401B (en) 1988-04-27
AU603375B2 (en) 1990-11-15
SE8703308D0 (sv) 1987-08-26
SG52393G (en) 1993-08-06

Similar Documents

Publication Publication Date Title
JP2001503737A (ja) 糖尿病の発生を防止するためのシブトラミン類似体の利用
JP2001500883A (ja) 低脂質値のためのシブトラミン類似物の使用
FR2530468A1 (fr) Composition analgesique et anti-inflammatoire contenant de l'ibuprofen
EP0255415B1 (fr) Utilisation de phényléthanolamines pour la préparation de médicaments agissant sur les troubles gastro-intestinaux
JPH0138087B2 (cs)
LU86973A1 (fr) Agent therapeutique pour le traitement des troubles associes a l'ischemie cerebrale
EP0738147A1 (fr) Application du riluzole dans le traitement des maladies mitochondriales
FR2896159A1 (fr) Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
US6011054A (en) Method for treating depression, obsessive compulsive disorder, and anxiety with N--acetyl serotonin
FR2721825A1 (fr) Compositions pharmaceutiques et procede permettant leur preparation
FR2530470A1 (fr) Composition comprenant un derive de vitamine d pour prevenir la fievre de lait chez la vache laitiere
EP0413694B1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
DE69307702T2 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
CH630608A5 (fr) Procedes de preparation de derives actifs de l'uree.
EP1007522B1 (fr) 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, sa preparation et son utilisation therapeutique
FR2544614A1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
BE1013314A3 (fr) Agent stimulant la liberation d'acetylcholine dans le cerveau.
JP3061445B2 (ja) 血管拡張剤
CH677731A5 (en) Use of isoquinoline derivs.
JP7257091B2 (ja) 認知症の治療及び予防薬
WO1998035670A1 (fr) Produit contenant de l'idazoxan et de la 1-dopa comme preparation pharmaceutique combinee utilise pour la maladie de parkinson
JPH0645539B2 (ja) 鎮痛剤
FR2650502A1 (fr) Nouvelle forme galenique orale ameliorant la biodisponibilite
FR2624120A1 (fr) Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes
FR2787328A1 (fr) Utilisation d'un antagoniste des recepteurs 5ht2a pour la preparation de medicaments utiles dans le traitement des ronflements et du syndrome de haute resistance ou de resistance des voies aeriennes superieures